AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2013
Aug 12, 2013
3174_iss_2013-08-12_ad5f596d-c878-4884-948d-20005c647434.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Östersjöstiftelsen
Instrument
| Instrument | aktier SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | 2,274,179 | |
| Voting rights | 2,274,179 | |
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 23/07/2013 | |
| Limit for number of shares | 20 % | |
| Limit for number of votes | 20 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 2,274,179 | |
| Directly held voting rights | 2,274,179 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 19.1 % | |
| Directly held voting rights | 19.1 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, |
first paragraph, line 3
-
Physically settled
-
Cash settled
Total
Group total holdings
Voting rights 2,274,179 Percentage of voting rights 19.1
Notes (other relevant informations according to law) Riktad nyemision till Bure Equity AB som förändrar ägarandelen.
Published
12/08/2013 09:30
Contact
Name Leticia Viseth Phone 08 7000 672 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13